Jessica Brim, NP
Primary Care · Salem, VANPI 1790867471
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 23.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,193 and has fallen 83.0% since, to $203 in 2025.
Across 90 payments — averaging $30.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$645
- Novo Nordisk$539
- Mannkind Corporation$393
- AbbVie$326
- Medtronic$139
- Madrigal Pharmaceuticals$118
- plus $574 from 14 others
What the payments were for
- Food & beverage$2,733100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 17 | $645 |
| Novo Nordisk | 8 | $539 |
| Mannkind Corporation | 23 | $393 |
| AbbVie | 10 | $326 |
| Medtronic | 2 | $139 |
| Madrigal Pharmaceuticals | 1 | $118 |
| Astellas Pharma US Inc | 1 | $99 |
| Lilly USA, LLC | 5 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $79 |
| Amarin Pharma, Inc. | 3 | $55 |
| Pfizer | 2 | $42 |
| Biohaven Pharmaceuticals, Inc. | 2 | $39 |
| Sunovion Pharmaceuticals Inc. | 4 | $37 |
| Amgen | 2 | $32 |
| Ultragenyx Pharmaceutical Inc. | 1 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $23 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $17 |
| Merck | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,733 in reported general payments places this provider in the 85th percentile of 142 primary care providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other primary care in Salem
- Rebecca GrinsellRichmond$12K
- Jennifer CampbellNewport News$8K
- Tien MaAnnandale$7K
- Michael CogginAshland$7K
- Erin StewartFredericksburg$6K
- Lawanda WoodNorfolk$6K
- Sara WeaverDanville$5K
- Luis Rivera PenaFalls Church$4K
- Erika RobinsonFredericksburg$4K
- Haley SwansonVirginia Beach$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.